UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 76,881 Shares of Maximus, Inc. $MMS

Key Points

• UBS Asset Management cut its Maximus stake by 41.1% in the second quarter, selling 76,881 shares and retaining 110,200 shares valued at approximately $5.9 million. Institutional investors collectively own 97.21% of the company.
• Analyst sentiment has weakened, with ratings ranging from Hold to Strong Sell; MarketBeat reports a consensus rating of “Reduce.”
• Maximus slightly exceeded quarterly EPS expectations at $2.22, but revenue fell 5.1% year over year to $1.28 billion, below estimates. The company maintained fiscal 2026 EPS guidance of $7.90–$8.20 and pays a $1.32 annualized dividend yielding about 2.3%.

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC reduced its position in Maximus, Inc. (NYSE:MMS - Free Report) by 41.1% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 110,200 shares of the health services provider's stock after selling 76,881 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.21% of Maximus worth $5,924,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Hsbc Holdings PLC raised its stake in Maximus by 310.1% in the second quarter. Hsbc Holdings PLC now owns 17,845 shares of the health services provider's stock valued at $956,000 after buying an additional 13,494 shares during the period. Archer Investment Corp bought a new position in shares of Maximus during the 2nd quarter worth approximately $43,000. Empowered Funds LLC bought a new position in shares of Maximus during the 2nd quarter worth approximately $504,000. Corient Private Wealth LP bought a new position in shares of Maximus during the 2nd quarter worth approximately $1,984,000. Finally, Bank of America Corp DE acquired a new position in shares of Maximus during the 2nd quarter worth approximately $31,487,000. Institutional investors own 97.21% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the company. Weiss Ratings reaffirmed a "hold (c-)" rating on shares of Maximus in a report on Monday, August 17th. Wall Street Zen cut shares of Maximus from a "buy" rating to a "hold" rating in a research note on Saturday, August 8th. Finally, Zacks Research lowered shares of Maximus from a "hold" rating to a "strong sell" rating in a research note on Tuesday, August 11th. One equities research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Reduce".

Maximus Stock Performance

Shares of NYSE MMS opened at $56.37 on Wednesday. The company has a debt-to-equity ratio of 0.90, a current ratio of 2.42 and a quick ratio of 2.42. The firm has a market cap of $2.95 billion, a price-to-earnings ratio of 8.33 and a beta of 0.59. The stock's fifty day moving average price is $58.03 and its two-hundred day moving average price is $62.69. Maximus, Inc. has a one year low of $52.73 and a one year high of $100.00.

Maximus (NYSE:MMS - Get Free Report) last posted its earnings results on Thursday, August 6th. The health services provider reported $2.22 earnings per share for the quarter, topping analysts' consensus estimates of $2.21 by $0.01. The company had revenue of $1.28 billion during the quarter, compared to the consensus estimate of $1.33 billion. Maximus had a return on equity of 24.91% and a net margin of 7.07%.The company's revenue was down 5.1% on a year-over-year basis. During the same quarter last year, the firm earned $2.16 earnings per share. Maximus has set its FY 2026 guidance at 7.900-8.200 EPS. On average, equities analysts forecast that Maximus, Inc. will post 8.03 EPS for the current year.

Maximus Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, August 31st. Shareholders of record on Friday, August 14th were paid a $0.33 dividend. The ex-dividend date was Friday, August 14th. This represents a $1.32 annualized dividend and a yield of 2.3%. Maximus's payout ratio is 19.50%.

Maximus Company Profile

Maximus, Inc NYSE: MMS is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children's Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.